0.68
0.68 (0%)
As of Apr 17, 2025
Salarius Pharmaceuticals, Inc. [SLRX]
Source:
Company Overview
Salarius is a clinical-stage biopharmaceutical company that has been focused on developing effective treatments for patients with cancer with high, unmet medical need. Specifically, Salarius has been concentrated on developing treatments for cancers caused by dysregulated gene expression (i.e., genes which are incorrectly turned on or off).
Country | United States |
Headquarters | houston, texas |
Phone Number | (832)834-9144 |
Industry | manufacturing |
CEO | David J. Arthur |
Website | clinicaltrials.gov |